STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1187 by analyst upside · 2026-06-27
CELC
Celcuity Inc.
Healthcare · Market Cap $5B · P/E 0x
ANALYST PRICE TARGET
+61.2%
implied upside to consensus target
Current Price $99.95
Consensus Target $161.09
Bull Target $175.0
Bear Target $145.0
Analysts Covering 11
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
9
Hold
1
Sell
0
52-Week Low $11.7
52-Week High $151.02
YTD Return -0.6%
FUNDAMENTALS
Market Cap $5B
P/E Ratio (TTM) N/A
Forward P/E 135.1x
EPS (TTM) $-4.06
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $11.7
52-Week High $151.02
Current Price $99.95
Bear Target $145.0
Bull Target $175.0
● Now $99.95 ● Target $161.09
TRADING DATA
Avg Volume 1.3M
YTD Return -0.6%
Analyst Count 11
Consensus Buy
Upside to Target +61.2%
Last Updated 2026-06-27

ANALYST SUMMARY

Celcuity Inc. (CELC) is currently trading at $99.95 with a Wall Street consensus price target of $161.09, implying potential upside of 61.2% over the next 12 months. 11 analysts currently cover CELC, with a consensus rating of Buy - 91% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $175.0, while the most cautious has a target of $145.0.

CELC operates in the Healthcare sector with a market capitalisation of $5B. The stock is down 0.6% year-to-date and is currently trading near the upper end of its 52-week range of $11.7 – $151.02.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CELC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Craig-Hallum — Reiterated
Buy → Buy 2026-06-03 Building track record
Wells Fargo — Reiterated
Overweight → Overweight 2026-06-03 Building track record
HC Wainwright & Co. — Reiterated
Buy → Buy 2026-06-03 31% win rate (48 calls)
HC Wainwright & Co. — Reiterated
Buy → Buy 2026-05-18 31% win rate (48 calls)
Wells Fargo — Reiterated
Overweight → Overweight 2026-05-15 Building track record
Needham reit
Buy → Buy 2026-05-15 20% win rate (5 calls)
Citizens — Reiterated
Market Outperform → Market Outperform 2026-05-04 Building track record
Guggenheim — Reiterated
Buy → Buy 2026-05-04 62% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
65
out of 100
Coverage depth
19/30
Consensus clarity
24/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →